Walgreens Boots Alliance, Inc. (NASDAQ:WBA) will release earnings results for its fiscal year 2025 first quarter, before the opening bell on Thursday, Jan. 9, 2025.
Analysts expect the Deerfield, Illinois-based company to report quarterly earnings at 40 cents per share, down from 66 cents per share in the year-ago period. Walgreens projects to report revenue of $37.37 billion for the recent quarter, compared to $36.71 billion a year earlier, according to data from Benzinga Pro.
According to a recent Wall Street Journal report, Walgreens has been discussing a deal with Sycamore Partners in which Walgreens would sell itself to the private-equity firm and pull the pharmacy chain from public markets.
Walgreens shares fell 3.7% to close at $9.26 on Monday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.
- Jefferies analyst Brian Tanquilut maintained a Hold rating and cut the price target from $19 to $9 on Oct. 23. This analyst has an accuracy rate of 64%.
- UBS analyst Kevin Caliendo maintained a Neutral rating and raised the price target from $9 to $10 on Oct. 17. This analyst has an accuracy rate of 70%.
- Morgan Stanley analyst Erin Wright maintained an Underweight rating and cut the price target from $9 to $7 on Oct. 11. This analyst has an accuracy rate of 74%.
- Truist Securities analyst David Macdonald maintained a Hold rating and slashed the price target from $13 to $10 on Oct. 7. This analyst has an accuracy rate of 64%.
- B of A Securities analyst Alien Lutz maintained an Underperform rating and lowered the price target from $11 to $7.5 on Sept. 4. This analyst has an accuracy rate of 70%.
Considering buying WBA stock? Here's what analysts think:
Read This Next:
- Top 3 Tech Stocks That May Fall Off A Cliff This Quarter
